Arrowhead Pharmaceuticals, Inc.
US
Arrowhead Pharmaceuticals, Inc.: 5 links from the documents of the companies and the register.
Customers 5
| Entity | Figure | Evidence | Documents |
|---|---|---|---|
| Amgen Inc. | Named as a major customer or supplier | Stated | Form 10-K for the fiscal year ended 30 September 2025 |
| Glaxosmithkline Intellectual Property Limited | Named as a major customer or supplier | Stated | Form 10-K for the fiscal year ended 30 September 2025 |
| Sanofi | Named as a major customer or supplier | Stated | Form 10-K for the fiscal year ended 30 September 2025 |
| Sarepta Therapeutics, Inc | Named as a major customer or supplier | Stated | Form 10-K for the fiscal year ended 30 September 2025 |
| Takeda Pharmaceuticals United States Of America Incorporated | Named as a major customer or supplier | Stated | Form 10-K for the fiscal year ended 30 September 2025 |
Each link names the documents that state it, with the class of its evidence: stated by one party, confirmed by both, or stated by the register of legal entities. A commitment is the commitment at the date of the agreement.